B. Metzler seel. Sohn & Co’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.3M Hold
10,259
0.02% 360
2025
Q4
$2.47M Buy
10,259
+1,501
+17% +$384K 0.02% 354
2025
Q3
$2.4M Hold
8,758
0.02% 352
2025
Q2
$2.26M Hold
8,758
0.02% 355
2025
Q1
$1.96M Buy
8,758
+1,928
+28% +$450K 0.02% 357
2024
Q4
$1.56M Sell
6,830
-195
-3% -$47K 0.02% 435
2024
Q3
$1.71M Hold
7,025
0.02% 426
2024
Q2
$1.34M Buy
7,025
+140
+2% +$28.4K 0.01% 464
2024
Q1
$1.36M Buy
6,885
+990
+17% +$181K 0.02% 454
2023
Q4
$1.01M Buy
5,895
+413
+8% +$63.5K 0.01% 507
2023
Q3
$811K Sell
5,482
-69,535
-93% -$12.6M 0.01% 504
2023
Q2
$16.4M Buy
75,017
+2,217
+3% +$494K 0.22% 63
2023
Q1
$15.9M Buy
72,800
+6,377
+10% +$1.38M 0.25% 63
2022
Q4
$13.8M Buy
66,423
+58,219
+710% +$12.8M 0.24% 73
2022
Q3
$1.79M Hold
8,204
0.03% 309
2022
Q2
$1.72M Hold
8,204
0.03% 331
2022
Q1
$1.99M Sell
8,204
-1,835
-18% -$444K 0.03% 339
2021
Q4
$2.63M Buy
10,039
+1,316
+15% +$341K 0.03% 281
2021
Q3
$2.3M Sell
8,723
-377
-4% -$103K 0.03% 286
2021
Q2
$2.24M Sell
9,100
-778
-8% -$164K 0.03% 280
2021
Q1
$1.92M Buy
9,878
+2,269
+30% +$455K 0.03% 299
2020
Q4
$1.67M Buy
+7,609
New +$1.52M 0.03% 307

Other funds holding RMD

B. Metzler seel. Sohn & Co's RMD Position: Q1 2026 in Review

B. Metzler seel. Sohn & Co held its ResMed (RMD) position steady in Q1 2026 at 10,259 shares worth $2.3M. The position accounts for 0.02% of the portfolio, ranked #360.

B. Metzler seel. Sohn & Co first reported a position in RMD in Q4 2020 and has held it in 22 quarters since. The position peaked at $16.4M in Q2 2023. 940 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • B. Metzler seel. Sohn & Co held 10,259 shares of ResMed worth $2.3M as of Q1 2026.
  • B. Metzler seel. Sohn & Co left its ResMed share count unchanged in Q1 2026.
  • ResMed made up 0.02% of B. Metzler seel. Sohn & Co's portfolio in Q1 2026, its #360 holding.
  • B. Metzler seel. Sohn & Co first reported a position in ResMed in Q4 2020 and has held it in 22 quarters since.
  • B. Metzler seel. Sohn & Co's ResMed position peaked at $16.4M in Q2 2023.
  • 940 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.